Navigation Links
Enox Biopharma, Inc. Expands Its Technology to Cover the Wound Care Market
Date:5/31/2011

VANCOUVER, British Columbia, May 31, 2011 /PRNewswire/ -- Enox Biopharma, Inc., a leader in the development of innovative solutions for infections associated with medical devices, today announced that it has expanded its technology to cover the wound care market by filing a patent application on novel means of delivering nitric oxide directly to wounds.

Nitric oxide is well recognized as both an antimicrobial agent which can prevent infections and as a vasodilator which can accelerate wound healing. The unstable nature of nitric oxide has, until now, prevented its clinical use. Enox Biopharma has already protected the dosing of polymers with nitric oxide which is sequestered in the polymer in a stable state. The nitric oxide remains in the polymer until it is used clinically at which point it emits nitric oxide over the period of weeks. Our new technology allows us to deliver nitric oxide directly to wounds which may prevent infections while expediting the healing process ultimately facilitating the closing of chronic wounds that would not otherwise heal.

"The inability to heal foot ulcers in the diabetic patient leads to over one million leg amputations per year according to the World Diabetes Foundation," noted Enox's founder and President Professor Yossef Av-Gay. "It is conceivable that we could replace this gruesome standard of care with a noninvasive nitric oxide delivery method. It will take time and clinical research to determine if this is indeed possible but the potential is certainly there."

John Rewcastle, Ph.D., Chief Executive Officer of Enox, commented, "The wound care market is drastically underserved today. Although we can't yet fully disclose the details of our patent application, we believe the novel delivery method, which we are in the process of fully protecting globally will meet the need of millions of patients worldwide. We are excited to contribute to the wound care market which is expected to exceed twenty billion do
'/>"/>

SOURCE Enox Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015
2. Enox Biopharma, Inc. Appoints Dr. John Rewcastle as CEO
3. Sinobiopharma, Inc. Appoints New Director of Marketing
4. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
5. BioStorage Technologies Expands U.S. Operations with Opening of New Biorepository Facility
6. DATATRAK Academy Expands to Include Durham Technical Community College
7. Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World
8. Practice Fusion Expands Executive Team with New VP of Marketing and Senior Business Development Director
9. Online Career Service for Postgraduate Life Scientists Expands Membership to Individuals
10. GeneWize Expands DNA Customization into 3 Mega Markets
11. China-Biotics Expands Product Supplied to Bright Dairy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... of molecular diagnostic test results. It also enables ... for the validation and reporting of high profile ... diagnostics is a rapidly growing area of biotechnology ... genetic predisposition, cancer, and companion diagnostics in personalized ...
(Date:7/23/2014)... 23, 2014  Sangamo BioSciences, Inc. (NASDAQ: ... results and accomplishments. For the second ... net loss of $7.0 million, or $0.10 per share, ... $0.10 per share, for the same period in 2013. ... cash equivalents, marketable securities and interest receivable of $236.7 ...
(Date:7/23/2014)... the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Vienna University of ... succeeded in embedding nearly perfect semiconductor crystals into ... producing hybrid nanowires, very fast and multi-functional processing ... in the future. The research results will be ... , Nano-optoelectronics are considered the cornerstone of future ...
(Date:7/23/2014)... 23, 2014 Shimadzu Scientific Instruments ... acid analysis system developed jointly with Ajinomoto Co. ... can analyze 38 amino acids in nine minutes, ... achieves high-speed analysis utilizing a fast application-specific column ... accurate analytical results even under conditions with difficult ...
Breaking Biology Technology:New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9A crystal wedding in the nanocosmos 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2
... SAN DIEGO, CA, July 30, 2009 Senomyx, Inc. (Nasdaq: ... on Tuesday, August 4, 2009 before the opening of the U.S. financial ... Internet broadcast that will provide a corporate update and a review of ... Time (8:00 a.m. Pacific Time). , , To participate ...
... , , ALPHARETTA, Ga., July ... announced the appointment of Philip Vogt as Executive Vice President, ... more than thirty years of pharmaceutical experience and will ... to this role, Vogt served as President of Ethex Corporation ...
... SOUTH SAN FRANCISCO, Calif., July 30 Sunesis Pharmaceuticals, ... on the development and commercialization of new oncology therapeutics for ... NASDAQ has approved its application to transfer the listing of ... NASDAQ Capital Market. The transfer will be effective at the ...
Cached Biology Technology:SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 2Sunesis Receives Approval for Listing on The NASDAQ Capital Market 3
(Date:7/24/2014)... cars ply silent freeways, solar panels blanket rooftops and ... from howling winds and from the blazing desert sun. ... technically and economically feasible to convert California,s all-purpose energy ... in Energy , the plan shows the way ... California that could create tens of thousands of jobs ...
(Date:7/24/2014)... Einstein College of Medicine of Yeshiva University have ... for Parkinson,s Research to translate a basic science finding ... project will test chemical compounds on a newly identified ... acts on an underlying cause of the disease. ... manage their symptoms, we are eager to stop or ...
(Date:7/24/2014)... in the United States, wildland managers often utilize the ... trees (ladder fuels). These cuttings and other post-logging ... danger in order to dispose of the material. To ... often cover all or part of the debris pile ... plastic, in order to keep water out. A recent ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3Study gives new perspective on agricultural plastic, debris burning, and air quality 2
... tomorrow (14 October) as CSIRO launches in the United ... 2006 in Atlanta, Georgia, the world's largest conference for ... mathematical method, patented by Australia's CSIRO, for automatically tracing ... With up to 40,000 delegates expected, the conference will ...
... for treating a recurrent cancer of the central nervous ... glioma, has shown promising results in preliminary data from ... from the first group of six patients in the ... Center, showed that vitespen (trademarked as Oncophage), a vaccine ...
... a few dozen trillions, a human adult has about 70 ... 959 cells. , Yet we have an awful lot ... been exploring two “highly conserved? cell-signaling pathways for innate immunity ... a lot of common enemies, particularly soil-borne pathogens. C. elegans, ...
Cached Biology News:Vaccine for brain tumors shows promising results 2Vaccine for brain tumors shows promising results 3Worms produce surprise insight into human fever 2
... polyclonal to ThPok ( Abpromise for all ... peptide conjugated to KLH derived from within residues ... (Note: the amino acid sequence is proprietary) ... Entrez Gene ID: 51043 ...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Pronase Reagent...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Biology Products: